Clinical trial
Effects of Metformin and Combination of Metformin and Pioglitazone on Plasma Interleukin-6 and Interleukin-8 Levels in Polycystic Ovarian Syndrome
NCT03117517 is registered in ClinicalTrials.gov with Khyber Medical University Peshawar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Metformin and Combination of Metformin and Pioglitazone on Plasma Interleukin-6 and Interleukin-8 Levels in Polycystic Ovarian Syndrome
- Lead sponsor
- Khyber Medical University Peshawar
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 20, 2017
- Completion date
- March 7, 2018
- Enrollment
- 106 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
polycystic ovarian syndrome